21 to 30 of 2,151 结果
application/x-netcdf - 1.6 MB - MD5: 7fa725baaca3ad85427c675c17d0467f
|
Tab-Delimited - 982.0 KB - MD5: 50486b202a5a1eb420d0346c296a1b2c
|
text/x-sh - 1.2 KB - MD5: f5a78c2c2225f983c0e7baf3d21923c5
|
2024-8-26
|
2024-8-24 - meta分析
孙爱民, 2024, "Supplementary data from a meta-analysis of tolizumab in the treatment of thyroid eye disease", https://doi.org/10.18170/DVN/PVRZGY, 北京大学开放研究数据平台, V1
|
2024-8-24 -
Supplementary data from a meta-analysis of tolizumab in the treatment of thyroid eye disease
MS Word (docx) - 17.1 KB - MD5: 9e2f54bb0a9f1f85da3544ce303adbe4
|
2024-8-24 -
Supplementary data from a meta-analysis of tolizumab in the treatment of thyroid eye disease
MS Word (docx) - 105.9 KB - MD5: f203366d92ec403bfc53c44c618405e9
|
2024-8-24
|
2024-8-20 - “HNF1A的低C反应蛋白等位基因与心血管疾病风险增加相关:一项荟萃分析”补充材料
杨超超; 纪立农; 韩学尧, 2024, "“HNF1A的低C反应蛋白等位基因与心血管疾病风险增加相关:一项荟萃分析”的补充材料", https://doi.org/10.18170/DVN/WKENNS, 北京大学开放研究数据平台, V3
|
MS Word (docx) - 4.4 MB - MD5: b29b46a436bad5f3773e09e62aedbe28
|